These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30222630)

  • 21. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
    Shimoda M; Mori S; Kita J; Sawada T; Kubota K
    Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of portal or superior mesenteric vein resection and reconstruction by allogeneic vein for pancreatic head cancer-a case-control study.
    Zhang XM; Zhang J; Fan H; He Q; Lang R
    BMC Gastroenterol; 2018 Apr; 18(1):49. PubMed ID: 29661201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Mizuno S; Kato H; Yamaue H; Fujii T; Satoi S; Saiura A; Murakami Y; Sho M; Yamamoto M; Isaji S
    Ann Surg; 2021 Jul; 274(1):e36-e44. PubMed ID: 31356273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection.
    Eguchi H; Ishikawa O; Ohigashi H; Takahashi H; Ohue M; Takenaka A; Tomita Y; Yano M
    Am J Surg; 2009 Nov; 198(5):e66-71. PubMed ID: 19887180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
    Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
    BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection.
    Gyoten K; Mizuno S; Nagata M; Ogura T; Usui M; Isaji S
    World J Surg; 2017 Aug; 41(8):2111-2120. PubMed ID: 28258459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
    Kleive D; Labori KJ; Line PD; Gladhaug IP; Verbeke CS
    HPB (Oxford); 2020 Jan; 22(1):50-57. PubMed ID: 31186199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
    Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
    Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
    Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
    Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
    [No Abstract]   [Full Text] [Related]  

  • 32. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head.
    Allema JH; Reinders ME; van Gulik TM; van Leeuwen DJ; de Wit LT; Verbeek PC; Gouma DJ
    Br J Surg; 1994 Nov; 81(11):1642-6. PubMed ID: 7827892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
    Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
    J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.
    Selvaggi F; Mascetta G; Daskalaki D; dal Molin M; Salvia R; Butturini G; Cellini C; Bassi C
    Langenbecks Arch Surg; 2014 Jun; 399(5):659-65. PubMed ID: 24777762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.
    Kim M; Kang TW; Cha DI; Kim YK; Kim SH; Jang KT; Han IW; Sohn I
    Clin Radiol; 2018 Jun; 73(6):564-573. PubMed ID: 29519500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?
    Kang H; Kim SS; Sung MJ; Jo JH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Park MS; Bang S
    Pancreatology; 2020 Jul; 20(5):952-959. PubMed ID: 32561070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.
    Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D
    Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.